Cargando…
Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646101/ http://dx.doi.org/10.1186/2051-1426-3-S2-P102 |
_version_ | 1782400914623037440 |
---|---|
author | Nair, Nitya Lemmens, Ed Enstrom, Amanda Chen, Shih-Yu Chang, Serena Le, Dung Jaffee, Elizabeth M Maecker, Holden Murphy, Aimee L Brockstedt, Dirk G Whiting, Chan |
author_facet | Nair, Nitya Lemmens, Ed Enstrom, Amanda Chen, Shih-Yu Chang, Serena Le, Dung Jaffee, Elizabeth M Maecker, Holden Murphy, Aimee L Brockstedt, Dirk G Whiting, Chan |
author_sort | Nair, Nitya |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4646101 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46461012015-11-20 Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer Nair, Nitya Lemmens, Ed Enstrom, Amanda Chen, Shih-Yu Chang, Serena Le, Dung Jaffee, Elizabeth M Maecker, Holden Murphy, Aimee L Brockstedt, Dirk G Whiting, Chan J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4646101/ http://dx.doi.org/10.1186/2051-1426-3-S2-P102 Text en Copyright © 2015 Nair et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Nair, Nitya Lemmens, Ed Enstrom, Amanda Chen, Shih-Yu Chang, Serena Le, Dung Jaffee, Elizabeth M Maecker, Holden Murphy, Aimee L Brockstedt, Dirk G Whiting, Chan Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer |
title | Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer |
title_full | Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer |
title_fullStr | Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer |
title_full_unstemmed | Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer |
title_short | Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer |
title_sort | long term survivors and immune biomarker analysis of phase iia, randomized study of gvax pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646101/ http://dx.doi.org/10.1186/2051-1426-3-S2-P102 |
work_keys_str_mv | AT nairnitya longtermsurvivorsandimmunebiomarkeranalysisofphaseiiarandomizedstudyofgvaxpancreasandcrs207immunotherapyinpatientswithmetastaticpancreaticcancer AT lemmensed longtermsurvivorsandimmunebiomarkeranalysisofphaseiiarandomizedstudyofgvaxpancreasandcrs207immunotherapyinpatientswithmetastaticpancreaticcancer AT enstromamanda longtermsurvivorsandimmunebiomarkeranalysisofphaseiiarandomizedstudyofgvaxpancreasandcrs207immunotherapyinpatientswithmetastaticpancreaticcancer AT chenshihyu longtermsurvivorsandimmunebiomarkeranalysisofphaseiiarandomizedstudyofgvaxpancreasandcrs207immunotherapyinpatientswithmetastaticpancreaticcancer AT changserena longtermsurvivorsandimmunebiomarkeranalysisofphaseiiarandomizedstudyofgvaxpancreasandcrs207immunotherapyinpatientswithmetastaticpancreaticcancer AT ledung longtermsurvivorsandimmunebiomarkeranalysisofphaseiiarandomizedstudyofgvaxpancreasandcrs207immunotherapyinpatientswithmetastaticpancreaticcancer AT jaffeeelizabethm longtermsurvivorsandimmunebiomarkeranalysisofphaseiiarandomizedstudyofgvaxpancreasandcrs207immunotherapyinpatientswithmetastaticpancreaticcancer AT maeckerholden longtermsurvivorsandimmunebiomarkeranalysisofphaseiiarandomizedstudyofgvaxpancreasandcrs207immunotherapyinpatientswithmetastaticpancreaticcancer AT murphyaimeel longtermsurvivorsandimmunebiomarkeranalysisofphaseiiarandomizedstudyofgvaxpancreasandcrs207immunotherapyinpatientswithmetastaticpancreaticcancer AT brockstedtdirkg longtermsurvivorsandimmunebiomarkeranalysisofphaseiiarandomizedstudyofgvaxpancreasandcrs207immunotherapyinpatientswithmetastaticpancreaticcancer AT whitingchan longtermsurvivorsandimmunebiomarkeranalysisofphaseiiarandomizedstudyofgvaxpancreasandcrs207immunotherapyinpatientswithmetastaticpancreaticcancer |